Phase II study of Paclitaxel and Epirubicin as Neoadjuvant Treatment for locally advanced Breast Cancer.

Trial Profile

Phase II study of Paclitaxel and Epirubicin as Neoadjuvant Treatment for locally advanced Breast Cancer.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 05 Jul 2016

At a glance

  • Drugs Epirubicin (Primary) ; Paclitaxel (Primary)
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Acronyms NAB
  • Most Recent Events

    • 05 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top